DYNE THERAPEUTICS INC (DYN) Stock Balance Sheet
NASDAQ:DYN - Nasdaq - US26818M1080 - Common Stock - Currency: USD
| 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 435.45M | 121.63M | 172.10M | 200.80M | 300.90M | |||
| Marketable Securities | 206.82M | 1.47M | 83.90M | 175.70M | 44.50M | |||
| Other Current Assets | 17.01M | 6.28M | 9.60M | 5.80M | 3.80M | |||
| Total Current Assets | 659.28M | 129.38M | 265.60M | 382.40M | 349.10M | |||
| Non-Current Assets | ||||||||
| PPE Net | 30.01M | 33.39M | 38.40M | 41.00M | 1.90M | |||
| Other Non-Current Assets | 1.94M | 2.31M | 2.30M | 2.30M | 2.30M | |||
| Total Non-Current Assets | 31.95M | 35.71M | 40.70M | 43.30M | 4.20M | |||
| TOTAL ASSETS | 691.23M | 165.08M | 306.30M | 425.70M | 353.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 35.70M | 28.16M | 22.80M | 24.70M | 7.50M | |||
| Accounts Payable | 6.56M | 22.94M | 5.30M | 4.00M | 3.40M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 42.26M | 51.09M | 28.10M | 28.70M | 11.00M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 19.14M | 22.70M | 25.90M | 28.70M | 0.00 | |||
| Total Non-Current Liabilities | 19.14M | 22.70M | 25.90M | 28.80M | 0.00 | |||
| TOTAL LIABILITIES | 61.40M | 73.79M | 54.00M | 57.50M | 11.00M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -949.93M | -632.51M | -396.60M | -228.50M | -79.20M | |||
| Additional Paid In Capital | 1.58B | 723.80M | 649.50M | 596.90M | 421.60M | |||
| Common Shares | 10.00K | 6.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | 6.00K | N/A | -600.00K | -300.00K | 0.00 | |||
| Shares Outstanding | 102.32M | 61.47M | 55.60M | 51.60M | 45.10M | |||
| Tangible Book Value per Share | 6.16 | 1.49 | 4.54 | 7.14 | 7.59 | |||
| Total Shareholders' Equity | 629.84M | 91.29M | 252.40M | 368.20M | 342.40M | |||
| TOTAL LIABILITIES AND EQUITY | 691.23M | 165.08M | 306.30M | 425.70M | 353.30M | |||
| Statistics | ||||||||
| Current Ratio | 15.60 | 2.53 | 9.45 | 13.32 | 31.74 | |||
| Return On Assets (ROA) | -45.92% | -142.92% | -54.88% | -35.07% | -16.82% | |||
| Return On Equity (ROE) | -50.40% | -258.44% | -66.60% | -40.55% | -17.36% | |||
All data in USD , ROIC based on taxRate of 0.21